ZEAL& Contact LinkedIn Twitter Search ABOUT ZEALAND PORTFOLIO R&D PARTNERING INVESTORS CAREERS AN INTRODUCTION TO ZEALAND Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (“Zealand”) is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi, Boehringer Ingelheim and Helsinn and a pipeline of proprietary product candidates, which primarily target specialty diseases with significant unmet needs. The company’s first invented medicine, lixisenatide, a once-daily prandial GLP-1 analog for the treatment of type 2 diabetes, is licensed to Sanofi. Lixisenatide is marketed as Lyxumia® outside the United States and approved as AdlyxinTM in the United States. Lixisenatide has been developed in a fixed-ratio combination with Lantus® (insulin glargine), referred to as iGlarLixi, which product is under regulatory review in the United States and in Europe. Zealand’s proprietary pipeline includes: Dasiglucagon* (ZP4207) as single-dose rescue treatment for acute, severe hypoglycemia (Phase II); Glepaglutide* (ZP1848) for treatment of short bowel syndrome (Phase II); Dasiglucagon* (ZP4207) multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management (in preparation for Phase II); and other earlier stage clinical and preclinical peptide therapeutics. Dasiglucagon and glepaglutide are proposed International Nonproprietary Names (pINN). The company is based in Copenhagen (Glostrup), Denmark. Zealand has ~110 employees of which 80% work in research and development. Follow us on Twitter: @ZealandPharma Follow us on LinkedIn An introduction to Zealand Privacy policy Legal Disclaimer Board of Directors and senior management History About Zealand Legal Disclaimer DOWNLOADS >>> Corporate Governance Corporate presentation and factsheet Financial calendar and reports CAREERS Current positions available Zealand as a work place ZEALAND PHARMA A/S Smedeland 36 2600 Glostrup (Copenhagen) Denmark Tel +45 88 77 36 00 info@zealandpharma.com